Unusual Peripheral Neuropathies. Part I: Extrinsic Causes

Matthew Grantz; Mengjing Chloe Huan

doi:10.1055/s-0030-1267282

Seminars in Neurology, Table of Contents

Semin Neurol 2010; 30(4): 387-395
DOI: 10.1055/s-0030-1267282

Unusual Peripheral Neuropathies. Part I: Extrinsic Causes

Matthew Grantz¹ , Mengjing Chloe Huan¹

¹Department of Neurology, University of Utah, Salt Lake City, Utah

Abstract

ABSTRACT

Peripheral neuropathy is common with many different etiologies. This is the first of three articles reviewing the less common causes of peripheral neuropathy. The first article includes the extrinsic causes of neuropathy including toxic/medications, infectious, nutritional, and systemic metabolic derangements. The second and third articles review the intrinsic causes of peripheral neuropathy. These reviews describe common presentations and constellation of manifestations and clinical findings.

KEYWORDS

Peripheral neuropathy - neuropathy - toxic-related neuropathy - heavy metal-related neuropathy - solvent-related neuropathy - infectious-related neuropathy - nutrition-related neuropathy

Full Text

References

REFERENCES

1 Baldereschi M, Inzitari M, Di Carlo A, Farchi G, Scafato E, Inzitari D. ILSA Working Group . Epidemiology of distal symmetrical neuropathies in the Italian elderly. Neurology. 2007; 68(18) 1460-1467
2 Dyck P J, Oviatt K F, Lambert E H. Intensive evaluation of referred unclassified neuropathies yields improved diagnosis. Ann Neurol. 1981; 10(3) 222-226
3 Lubec D, Müllbacher W, Finsterer J, Mamoli B. Diagnostic work-up in peripheral neuropathy: an analysis of 171 cases. Postgrad Med J. 1999; 75(890) 723-727
4 Smith A G, Singleton J R. The diagnostic yield of a standardized approach to idiopathic sensory-predominant neuropathy. Arch Intern Med. 2004; 164(9) 1021-1025
5 Martyn C N, Hughes R A. Epidemiology of peripheral neuropathy. J Neurol Neurosurg Psychiatry. 1997; 62(4) 310-318
6 Emery A E. Population frequencies of inherited neuromuscular diseases—a world survey. Neuromuscul Disord. 1991; 1(1) 19-29
7 Mold J W, Vesely S K, Keyl B A, Schenk J B, Roberts M. The prevalence, predictors, and consequences of peripheral sensory neuropathy in older patients. J Am Board Fam Pract. 2004; 17(5) 309-318
8 Aronson J K, Dukes M NG. Meyler's Side Effects of Drugs: The International Encyclopedia of Adverse Drug Reactions and Interactions. 15th ed. Amsterdam/Boston; Elsevier 2006
9 Davies D M. Textbook of Adverse Drug Reactions. 4th ed. Oxford/New York; Oxford University Press 1991: xiv, 879
10 PDR Guide to Drug Interactions, Side Effects, and Indications. Montvale, NJ; Thomson PDR 2006: v
11 Argov Z, Mastaglia F L. Drug-induced peripheral neuropathies. BMJ. 1979; 1(6164) 663-666
12 Charness M E, Morady F, Scheinman M M. Frequent neurologic toxicity associated with amiodarone therapy. Neurology. 1984; 34(5) 669-671
13 Kuncl R W, Cornblath D R, Avila O, Duncan G. Electrodiagnosis of human colchicine myoneuropathy. Muscle Nerve. 1989; 12(5) 360-364
14 Simpson D M. Selected peripheral neuropathies associated with human immunodeficiency virus infection and antiretroviral therapy. J Neurovirol. 2002; 8(Suppl 2) 33-41
15 Holmberg L, Boman G, Böttiger L E, Eriksson B, Spross R, Wessling A. Adverse reactions to nitrofurantoin. Analysis of 921 reports. Am J Med. 1980; 69(5) 733-738
16 Schaumburg H, Kaplan J, Windebank A et al.. Sensory neuropathy from pyridoxine abuse. A new megavitamin syndrome. N Engl J Med. 1983; 309(8) 445-448
17 Phan T, McLeod J G, Pollard J D, Peiris O, Rohan A, Halpern J P. Peripheral neuropathy associated with simvastatin. J Neurol Neurosurg Psychiatry. 1995; 58(5) 625-628
18 Chong P H, Boskovich A, Stevkovic N, Bartt R E. Statin-associated peripheral neuropathy: review of the literature. Pharmacotherapy. 2004; 24(9) 1194-1203
19 Wolf S, Barton D, Kottschade L, Grothey A, Loprinzi C. Chemotherapy-induced peripheral neuropathy: prevention and treatment strategies. Eur J Cancer. 2008; 44(11) 1507-1515
20 London Z, Albers J W. Toxic neuropathies associated with pharmaceutic and industrial agents. Neurol Clin. 2007; 25(1) 257-276
21 Siegal T, Haim N. Cisplatin-induced peripheral neuropathy. Frequent off-therapy deterioration, demyelinating syndromes, and muscle cramps. Cancer. 1990; 66(6) 1117-1123
22 Koike H, Iijima M, Sugiura M et al.. Alcoholic neuropathy is clinicopathologically distinct from thiamine-deficiency neuropathy. Ann Neurol. 2003; 54(1) 19-29
23 Kuwabara S, Kai M R, Nagase H, Hattori T. n-Hexane neuropathy caused by addictive inhalation: clinical and electrophysiological features. Eur Neurol. 1999; 41(3) 163-167
24 Chang Y C. Patients with n-hexane induced polyneuropathy: a clinical follow up. Br J Ind Med. 1990; 47(7) 485-489
25 Smith A G, Albers J W. n-Hexane neuropathy due to rubber cement sniffing. Muscle Nerve. 1997; 20(11) 1445-1450
26 Schaumburg H H, Spencer P S. Degeneration in central and peripheral nervous systems produced by pure n-hexane: an experimental study. Brain. 1976; 99(2) 183-192
27 Jones H B, Cavanagh J B. Distortions of the nodes of Ranvier from axonal distension by filamentous masses in hexacarbon intoxication. J Neurocytol. 1983; 12(3) 439-458
28 Kumar N. Neurologic presentations of nutritional deficiencies. Neurol Clin. 2010; 28(1) 107-170
29 Berger J R. The neurological complications of bariatric surgery. Arch Neurol. 2004; 61(8) 1185-1189
30 Skeen M B. Neurologic manifestations of gastrointestinal disease. Neurol Clin. 2002; 20(1) 195-225, vii vii
31 Koffman B M, Greenfield L J, Ali I I, Pirzada N A. Neurologic complications after surgery for obesity. Muscle Nerve. 2006; 33(2) 166-176
32 Juhasz-Pocsine K, Rudnicki S A, Archer R L, Harik S I. Neurologic complications of gastric bypass surgery for morbid obesity. Neurology. 2007; 68(21) 1843-1850
33 Green R, Kinsella L J. Current concepts in the diagnosis of cobalamin deficiency. Neurology. 1995; 45(8) 1435-1440
34 Kinsella L J, Green R. ‘Anesthesia paresthetica’: nitrous oxide-induced cobalamin deficiency. Neurology. 1995; 45(8) 1608-1610
35 Amaral J F, Thompson W R, Caldwell M D, Martin H F, Randall H T. Prospective hematologic evaluation of gastric exclusion surgery for morbid obesity. Ann Surg. 1985; 201(2) 186-193
36 Saperstein D S, Wolfe G I, Gronseth G S et al.. Challenges in the identification of cobalamin-deficiency polyneuropathy. Arch Neurol. 2003; 60(9) 1296-1301
37 Ohnishi A, Tsuji S, Igisu H et al.. Beriberi neuropathy. Morphometric study of sural nerve. J Neurol Sci. 1980; 45(2-3) 177-190
38 Kumar N, Boes C J, Vilensky J. Neurologic sequelae of deficiency diseases in World War II prisoners of war: extracts from a videographic narrative. J Clin Neurosci. 2010; 17(3) 294-295
39 Henri-Bhargava A, Melmed C, Glikstein R, Schipper H M. Neurologic impairment due to vitamin E and copper deficiencies in celiac disease. Neurology. 2008; 71(11) 860-861
40 Kumar N, Low P A. Myeloneuropathy and anemia due to copper malabsorption. J Neurol. 2004; 251(6) 747-749
41 Goodman B P, Bosch E P, Ross M A, Hoffman-Snyder C, Dodick D D, Smith B E. Clinical and electrodiagnostic findings in copper deficiency myeloneuropathy. J Neurol Neurosurg Psychiatry. 2009; 80(5) 524-527
42 Weihl C C, Lopate G. Motor neuron disease associated with copper deficiency. Muscle Nerve. 2006; 34(6) 789-793
43 Nations S P, Boyer P J, Love L A et al.. Denture cream: an unusual source of excess zinc, leading to hypocupremia and neurologic disease. Neurology. 2008; 71(9) 639-643
44 Rosenbaum R. Neuromuscular complications of connective tissue diseases. Muscle Nerve. 2001; 24(2) 154-169
45 Said G. Infectious neuropathies. Neurol Clin. 2007; 25(1) 115-137
46 Soysal A, Atay T, Ozu T, Arpaci B. Electrophysiological evaluation of peripheral and autonomic involvement in leprosy. Can J Neurol Sci. 2004; 31(3) 357-362
47 Marques Jr W, Foss N T, Arruda A P, Barreira A A. Near-nerve potential in lepromatous leprosy. Muscle Nerve. 2003; 28(4) 460-463
48 Mygland A, Skarpaas T, Ljøstad U. Chronic polyneuropathy and Lyme disease. Eur J Neurol. 2006; 13(11) 1213-1215
49 Ferrari S, Vento S, Monaco S et al.. Human immunodeficiency virus-associated peripheral neuropathies. Mayo Clin Proc. 2006; 81(2) 213-219
50 Ellis R J, Rosario D, Clifford D B CHARTER Study Group et al. Continued high prevalence and adverse clinical impact of human immunodeficiency virus-associated sensory neuropathy in the era of combination antiretroviral therapy: the CHARTER Study. Arch Neurol. 2010; 67(5) 552-558
51 Alpa M, Ferrero B, Cavallo R et al.. Anti-neuronal antibodies in patients with HCV-related mixed cryoglobulinemia. Autoimmun Rev. 2008; 8(1) 56-58
52 Feibel J H, Campa J F. Thyrotoxic neuropathy (Basedow's paraplegia). J Neurol Neurosurg Psychiatry. 1976; 39(5) 491-497
53 Torres C F, Moxley R T. Hypothyroid neuropathy and myopathy: clinical and electrodiagnostic longitudinal findings. J Neurol. 1990; 237(4) 271-274
54 Ørstavik K, Norheim I, Jørum E. Pain and small-fiber neuropathy in patients with hypothyroidism. Neurology. 2006; 67(5) 786-791
55 McManis P G, Windebank A J, Kiziltan M. Neuropathy associated with hyperlipidemia. Neurology. 1994; 44(11) 2185-2186
56 Delaney P. Gouty neuropathy. Arch Neurol. 1983; 40(13) 823-824

Matthew GrantzM.D.

Department of Neurology, University of Utah

175 North Medical Drive, Salt Lake City, UT 84132

Email: Matthew.Grantz@hsc.utah.edu